ABCG2 and cancer: For serum pathway enrichment analysis, PLS-DA identified 13 sub-pathways that were significantly different between disease cases and HCs, including choline metabolism in cancer, d-glutamine and d-glutamate metabolism, purine metabolism, glycerophospholipid metabolism, ABC transporters, and arginine and proline metabolism (Figure 5D).